PHARMACOLOGICAL MANAGEMENT OF THE AGITATED AND VIOLENT PATIENT IN REAL-WORLD SETTINGS 2026 by DrRamonReyesMD

 

PHARMACOLOGICAL MANAGEMENT OF THE AGITATED AND VIOLENT PATIENT IN REAL-WORLD SETTINGS

What is actually available in ambulances, emergency departments and EMS systems worldwide

International operational and scientific review 2026

By DrRamonReyesMD ⚕️ | Updated 2026

---

INTRODUCTION

Modern emergency medicine has finally accepted an uncomfortable truth:

many patients labelled as “aggressive” are not merely behavioural problems.

They may be physiologically close to collapse.

For decades, the traditional approach focused on:

sedating behaviour,

reducing combativeness,

controlling the scene.

However, contemporary emergency medicine, EMS and operational medicine recognise that many violently agitated patients may simultaneously present with:

hypoxia,

hypercapnia,

severe adrenergic discharge,

metabolic acidosis,

hyperthermia,

rhabdomyolysis,

catecholamine storm,

muscular exhaustion,

autonomic instability,

sudden cardiac death risk.

In this context, prolonged physical struggle, poor restraint technique, prone positioning, chest compression and inappropriate sedation may precipitate:

sudden death,

respiratory arrest,

ventricular arrhythmia,

metabolic collapse,

cardiorespiratory arrest.

---

THE DIFFERENCE BETWEEN TEXTBOOK MEDICINE AND THE STREET

Academic literature often describes ideal scenarios:

multiple drugs available,

immediate psychiatrist,

dedicated restraint room,

complete monitoring,

trained security personnel,

rapid laboratory testing,

abundant staff.

Real-world EMS is often different.

It may be:

a small ambulance,

extreme heat,

low light,

family members shouting,

police under stress,

limited staff,

limited drugs,

limited monitoring,

and one patient who may be dangerous to himself, the crew and the environment.

In many EMS systems:

droperidol is unavailable,

intramuscular olanzapine is not stocked,

lorazepam may be scarce,

diphenhydramine/Benadryl may not be part of the operational formulary,

IV haloperidol may be legally or clinically restricted,

ketamine may be limited by law, training or medical direction,

and many physicians or paramedics may only have:

midazolam,

diazepam,

haloperidol,

and clinical judgement.

---

FIRST PRINCIPLE: “AGGRESSIVE PATIENT” IS NOT A DIAGNOSIS

Agitation is a clinical sign.

It is not an aetiology.

An agitated or violent patient may actually have:

hypoxia,

hypoglycaemia,

sepsis,

traumatic brain injury,

intracranial haemorrhage,

postictal state,

alcohol withdrawal,

sympathomimetic intoxication,

serotonin syndrome,

neuroleptic malignant syndrome,

hyperthermia,

delirium,

encephalopathy,

primary psychosis,

or severe drug intoxication.

Incorrect sedation can:

worsen hypoxia,

cause respiratory arrest,

mask neurological deterioration,

worsen hypotension,

increase mortality.

---

THE PHYSIOLOGY OF EXTREME AGITATION

The violently agitated patient is not only “difficult”.

He may be burning oxygen, glucose and ATP at a catastrophic rate.

Severe agitation may produce:

massive catecholamine release,

tachycardia,

hypertension,

hyperthermia,

lactic acidosis,

hypovolaemia,

rhabdomyolysis,

hyperkalaemia,

cardiac irritability,

exhaustion followed by sudden collapse.

The danger is not only the behaviour.

The danger is the physiology behind the behaviour.

---

EXCITED DELIRIUM vs EXCITED PHYSIOLOGY

The term “excited delirium” remains medically, politically and legally controversial.

However, the operational physiology is real:

extreme agitation,

hyperthermia,

abnormal strength,

pain resistance,

confusion,

incoherent behaviour,

sympathomimetic intoxication,

severe acidosis,

sudden death risk.

Many modern EMS clinicians prefer the term:

Excited Physiology

because it describes the dangerous metabolic and autonomic state without relying on a controversial forensic label.

---

PHYSICAL RESTRAINT CAN KILL

This must be stated clearly.

Physical restraint is sometimes necessary, but it is not benign.

Risk increases with:

prone positioning,

chest compression,

neck compression,

multiple operators lying over the patient,

prolonged struggle,

delayed sedation,

hyperthermia,

stimulant intoxication,

metabolic acidosis.

A patient fighting against restraint may develop rapidly worsening lactic acidosis and oxygen debt.

The safest restraint is usually:

brief,

coordinated,

supine or lateral when possible,

with airway access,

rapid chemical sedation when indicated,

continuous monitoring.

---

MODERN PRINCIPLE 2026

Chemical sedation should not be seen as “chemical punishment”.

It should be understood as:

a physiological intervention to stop catastrophic adrenergic and metabolic escalation.

---

REAL-WORLD DRUG AVAILABILITY

Spain and many European EMS systems

Commonly available:

midazolam,

diazepam,

haloperidol,

sometimes levomepromazine,

sometimes chlorpromazine,

ketamine depending on service, medical direction and training.

Less commonly available:

droperidol,

intramuscular olanzapine,

ziprasidone,

prehospital dexmedetomidine,

lorazepam IM/IV.

---

United States

More common access to:

droperidol,

ketamine,

midazolam,

olanzapine IM,

ziprasidone,

lorazepam,

haloperidol,

diphenhydramine.

---

Latin America, Africa and austere environments

Very common:

diazepam,

midazolam,

haloperidol.

Variable:

ketamine.

Often rare or unavailable:

droperidol,

olanzapine IM,

ziprasidone,

dexmedetomidine.

---

THE MYTH OF THE UNIVERSAL B52

The classic B52 protocol consists of:

Diphenhydramine 50 mg,

Haloperidol 5 mg,

Lorazepam 2 mg,

usually given intramuscularly.

It became popular because it was:

simple,

memorable,

effective,

cheap,

widely available in many American emergency departments.

But it is not universal.

It is not globally available.

It is not always the safest option.

And many centres have moved away from routine B52 use.

---

WHY B52 IS BEING QUESTIONED

Excessive sedation

Especially in:

elderly patients,

alcohol intoxication,

mixed intoxication,

COPD,

obesity,

sleep apnoea,

frailty.

Diphenhydramine burden

Diphenhydramine may increase:

delirium,

anticholinergic toxicity,

sedation duration,

confusion,

delayed recovery.

Lorazepam availability

Lorazepam is not consistently stocked in many EMS systems outside the United States.

Operational limitation

B52 is a hospital-style cocktail.

It is not always appropriate for ambulances, remote settings or low-resource EMS.

---

A MORE GLOBAL B52-STYLE APPROACH

A realistic international equivalent must use drugs that actually exist in most systems.

The most globally accessible “B52-adjacent” combination is:

Haloperidol + Midazolam

Typical adult operational option:

Haloperidol 5 mg IM

plus

Midazolam 5 mg IM

This is often more realistic than B52 because both drugs are widely available in many countries.

---

WHY HALOPERIDOL + MIDAZOLAM WORKS

It covers two major pathways.

Haloperidol

Targets:

dopaminergic psychosis,

paranoid agitation,

psychotic delirium,

behavioural escalation related to hallucinations or delusions.

Midazolam

Targets:

sympathetic overdrive,

panic,

severe anxiety,

stimulant-associated adrenergic excitation,

muscle activity and struggle.

Together, they provide:

antipsychotic control,

anxiolysis,

sedation,

reduced catecholamine drive,

reduced struggle,

improved operational safety.

---

LEVEL 1: MILD TO MODERATE AGITATION

Goal:

avoid escalation,

preserve airway reflexes,

avoid deep sedation,

maintain communication when possible.

Options:

verbal de-escalation,

environmental control,

remove audience,

reduce noise,

avoid humiliation,

offer oral medication when safe.

Possible pharmacological options:

oral diazepam,

oral lorazepam where available,

oral olanzapine where available,

oral haloperidol,

intranasal midazolam if escalation is likely.

---

MIDAZOLAM

Common EMS dosing:

5 mg IM,

5–10 mg IN,

2–5 mg IV titrated slowly where IV access already exists.

Advantages:

rapid onset,

widely available,

excellent intranasal route,

useful when IV access is impossible,

effective for stimulant intoxication.

Risks:

respiratory depression,

hypoventilation,

apnoea,

paradoxical disinhibition,

worsening airway risk when combined with alcohol, opioids or sedatives.

Best fit:

sympathomimetic intoxication,

severe anxiety,

stimulant-driven agitation,

alcohol withdrawal,

serotonergic agitation,

patients requiring rapid calming but not deep dissociation.

---

HALOPERIDOL

Common adult dose:

5 mg IM.

Sometimes:

2.5 mg IM in frail or elderly patients,

5–10 mg IM in severe cases depending on protocol.

Strengths:

cheap,

widely available,

effective in psychosis,

less respiratory depression than benzodiazepines alone,

useful where droperidol or olanzapine are unavailable.

Risks:

QT prolongation,

torsades risk in predisposed patients,

acute dystonia,

akathisia,

neuroleptic malignant syndrome,

slower onset than benzodiazepines or ketamine.

Avoid or use caution in:

known prolonged QT,

hypokalaemia,

hypomagnesaemia,

methadone use,

cocaine intoxication with arrhythmia risk,

polypharmacy with QT-prolonging drugs,

Parkinson disease,

Lewy body dementia.

---

HALOPERIDOL + MIDAZOLAM

This is probably the most globally practical combination for severe agitation where ketamine is not available or not indicated.

Typical adult option:

Haloperidol 5 mg IM

plus

Midazolam 5 mg IM.

Clinical role:

psychosis with dangerous agitation,

mixed psychiatric and adrenergic agitation,

severe agitation without immediate need for dissociative sedation,

EMS systems without droperidol or olanzapine IM.

Advantages:

widely available,

easy to remember,

B52-style simplicity,

less dependent on U.S.-specific drug availability,

combines antipsychotic and benzodiazepine effects.

Risks:

oversedation,

respiratory depression from midazolam,

QT effects from haloperidol,

need for monitoring.

---

DROPERIDOL

Droperidol has returned strongly in many modern EMS and emergency medicine systems.

Typical doses:

5–10 mg IM,

2.5–5 mg IV titrated.

Advantages:

rapid,

effective,

often less need for rescue medication,

excellent for agitation and nausea,

increasingly supported by emergency medicine literature.

Risks:

QT prolongation concern,

although modern evidence suggests the historical black-box fear was probably excessive when used appropriately.

Limitations:

not available in many countries,

often not stocked in ambulances,

requires protocol approval.

---

OLANZAPINE

Useful for psychiatric agitation.

Typical doses:

5–10 mg IM or oral/ODT where available.

Advantages:

good antipsychotic effect,

less extrapyramidal toxicity than haloperidol,

useful in primary psychiatric agitation.

Critical warning:

avoid close co-administration with benzodiazepines, especially IM, because of risk of excessive sedation and cardiorespiratory depression.

Limitations:

not universally stocked,

IM form often unavailable in EMS.

---

KETAMINE

Ketamine changed prehospital management of violent agitation.

It is not merely a sedative.

At appropriate doses it produces dissociation.

This can rapidly stop catastrophic physical struggle.

Best fit:

violent patient impossible to control,

immediate danger to crew or patient,

excited physiology,

severe stimulant intoxication with uncontrollable combativeness,

failed conventional sedation,

need for rapid safe access.

Common EMS dosing:

3–5 mg/kg IM,

1–2 mg/kg IV.

Many EMS systems use approximately:

4 mg/kg IM

as a practical operational midpoint.

Advantages:

very rapid control,

preserves airway reflexes better than many deep sedatives,

maintains blood pressure in many patients,

excellent for extreme violence.

Risks:

hypersalivation,

vomiting,

emergence reaction,

hypertension,

tachycardia,

rare laryngospasm,

need for airway management,

possible intubation in some EMS systems after administration.

Operational truth:

ketamine should only be used where the team can monitor, oxygenate, suction, ventilate and escalate airway care if required.

---

DIAZEPAM

In many countries diazepam is more available than lorazepam.

Routes:

IV,

rectal,

oral,

sometimes IM but IM absorption is less reliable.

Advantages:

widely available,

useful for alcohol withdrawal,

seizures,

stimulant toxicity,

serotonergic toxicity.

Limitations:

slower and less predictable IM absorption,

longer half-life,

respiratory depression risk,

accumulation in elderly or hepatic disease.

---

LEVOMEPROMAZINE AND CHLORPROMAZINE

These drugs may exist in some European or Latin American hospital settings.

They are not ideal EMS first-line agents for violent agitation.

Risks include:

hypotension,

anticholinergic effects,

excessive sedation,

lower seizure threshold,

QT prolongation.

They may have a role in selected psychiatric settings, but they are less attractive for unstable emergency physiology.

---

PRACTICAL PROTOCOL BY CLINICAL PHENOTYPE

1. Primary psychosis with aggression

Preferred where available:

olanzapine IM,

droperidol,

haloperidol.

Resource-limited option:

haloperidol 5 mg IM.

If dangerous or escalating:

haloperidol 5 mg IM + midazolam 5 mg IM.

---

2. Stimulant intoxication

Examples:

cocaine,

methamphetamine,

MDMA,

synthetic cathinones.

Preferred:

benzodiazepines first.

Options:

midazolam 5 mg IM/IN,

diazepam IV titrated,

lorazepam where available.

If psychosis remains severe:

add haloperidol or droperidol with ECG/QT caution.

---

3. Alcohol withdrawal

Preferred:

benzodiazepines.

Options:

diazepam,

lorazepam,

midazolam.

Avoid antipsychotic monotherapy because it does not treat the withdrawal physiology and may lower seizure threshold.

---

4. Alcohol intoxication

Use caution.

These patients are already CNS-depressed.

Avoid stacking sedatives unless danger is immediate.

If medication is required:

low-dose antipsychotic may be preferable to benzodiazepine-heavy sedation depending on protocol and monitoring.

---

5. Delirium from medical illness

Think sepsis, hypoxia, hypoglycaemia, stroke, renal failure, hepatic failure.

Treat cause.

Use the lowest effective sedating dose.

Avoid turning a medical emergency into a “psychiatric” case.

---

6. Extreme violence / excited physiology

Priority:

scene safety,

rapid coordinated restraint,

avoid prone compression,

rapid sedation,

oxygen,

cooling if hyperthermic,

monitoring,

IV/IO access when safe,

treat acidosis, rhabdomyolysis and hyperkalaemia risk.

Medication:

ketamine IM if available and authorised,

or haloperidol + midazolam where ketamine is unavailable,

or midazolam escalation where antipsychotics are inappropriate.

---

GLOBAL LOW-RESOURCE ALGORITHM

Step 0: Safety and diagnosis

Do not rush blindly.

Check:

airway,

breathing,

circulation,

glucose,

temperature,

oxygen saturation,

trauma signs,

toxidrome,

medication history when possible.

---

Step 1: Mild agitation

verbal de-escalation,

environmental control,

oral medication if safe.

---

Step 2: Moderate agitation

midazolam 5 mg IN/IM,

or haloperidol 5 mg IM if psychotic phenotype predominates.

---

Step 3: Severe agitation

haloperidol 5 mg IM + midazolam 5 mg IM.

---

Step 4: Extreme violence

ketamine 3–5 mg/kg IM if available, authorised and the team can manage airway risk.

---

Step 5: After sedation

monitor continuously,

place patient supine or lateral,

avoid prone restraint,

oxygen as needed,

capnography if available,

ECG,

blood pressure,

temperature,

glucose,

reassess every few minutes.

---

MONITORING IS NOT OPTIONAL

The most dangerous phrase is:

“we gave the injection and he finally calmed down.”

A silent, sedated patient may be:

hypoventilating,

hypoxic,

hypercapnic,

aspirating,

arrhythmic,

hypotensive,

hyperthermic,

or dying.

Minimum monitoring after chemical sedation:

SpO₂,

respiratory rate,

blood pressure,

heart rate,

level of consciousness,

glucose,

temperature.

Preferred monitoring:

ECG,

capnography/ETCO₂,

serial vitals,

airway equipment immediately available.

---

CAPNOGRAPHY: THE SILENT LIFE-SAVER

Pulse oximetry may remain normal for several minutes, especially with supplemental oxygen.

Capnography detects:

apnoea,

hypoventilation,

airway obstruction,

sedation-related respiratory depression,

ventilatory failure.

For sedated agitated patients, ETCO₂ is one of the most valuable tools in EMS and emergency departments.

---

KEY OPERATIONAL ERRORS

The most common errors are:

treating agitation as purely psychiatric,

not checking glucose,

forgetting hypoxia,

using benzodiazepines blindly in alcohol intoxication,

using antipsychotic monotherapy in alcohol withdrawal,

using haloperidol without QT awareness,

giving ketamine without airway readiness,

restraining prone,

compressing the chest,

failing to monitor after sedation,

waiting too long while the patient fights himself into acidosis.

---

THE MOST PRACTICAL WORLDWIDE TAKEAWAY

The best protocol is not the most elegant.

The best protocol is:

available,

trained,

understood,

monitored,

legally authorised,

and physiologically appropriate.

In 2026, the most realistic global core is:

Midazolam for adrenergic agitation.

Haloperidol for psychotic agitation.

Haloperidol + Midazolam as the most practical B52-style global combination.

Ketamine for extreme violence and excited physiology when available and properly supported.

---

REFERENCES AND AUTHORITATIVE SOURCES

American Association for Emergency Psychiatry, Project BETA:
The Assessment and Management of Agitation.
West J Emerg Med. 2012.
DOI: 10.5811/westjem.2011.9.6866
URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3298219/

ACEP — American College of Emergency Physicians.
Emergency medicine clinical policies and agitation resources.
URL: https://www.acep.org/

NAEMSP — National Association of EMS Physicians.
Prehospital medical direction and EMS medication practice.
URL: https://naemsp.org/

Droperidol safety and efficacy literature.
Annals of Emergency Medicine.
DOI: 10.1016/j.annemergmed.2019.03.021

Ketamine for severe agitation literature.
American Journal of Emergency Medicine.
DOI: 10.1016/j.ajem.2018.10.049

Excited delirium / excited physiology review.
Academic Emergency Medicine.
DOI: 10.1111/acem.12948

Deployed Medicine / CoTCCC operational medicine resources.
URL: https://deployedmedicine.com/

---

FINAL CONCLUSION

The violent patient is not merely a behavioural problem.

He may be a metabolically collapsing patient.

The goal is not simply to “calm him down”.

The goal is to:

stop catastrophic struggle,

protect ventilation,

reduce catecholamine storm,

prevent acidosis,

avoid sudden death,

protect the crew,

protect the patient,

and maintain operational control.

In real-world EMS, the most globally credible and accessible B52-style alternative remains:

Haloperidol + Midazolam

while ketamine remains the most decisive option for extreme violence and excited physiology when the system is trained, equipped and authorised to use it.

By DrRamonReyesMD ⚕️ | Updated 2026